{{Rsnum
|rsid=15285
|Gene=LPL
|Chromosome=8
|position=19967156
|Orientation=minus
|GMAF=0.3292
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=LPL
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 35.4 | 54.0
| HCB | 2.9 | 30.7 | 66.4
| JPT | 7.1 | 27.4 | 65.5
| YRI | 32.9 | 50.0 | 17.1
| ASW | 12.3 | 68.4 | 19.3
| CHB | 2.9 | 30.7 | 66.4
| CHD | 5.5 | 33.0 | 61.5
| GIH | 2.0 | 35.6 | 62.4
| LWK | 32.1 | 45.9 | 22.0
| MEX | 12.1 | 36.2 | 51.7
| MKK | 22.4 | 53.2 | 24.4
| TSI | 14.7 | 39.2 | 46.1
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21386085
|Trait=None
|Title=A Bivariate Genome-Wide Approach to Metabolic Syndrome: STAMPEED Consortium
|RiskAllele=A
|Pval=1E-10
|OR=0.2700
|ORtxt=[0.19-0.35] unit decrease
|OA=1
}}

{{PMID Auto
|PMID=19148283
|Title=Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}